Abstract:
The microbiome represents an exciting frontier in medicine, and early successes in the field have demonstrated the dynamic interactions among individual microbial species and highlighted the crosstalk between microbiota and their hosts at the mucosal interface. In this talk, I will present our work from the past few years in interrogating and manipulating commensal bacteria and probiotics as therapeutic platforms to promote human health.

Bio:
Dr. Li earned his PhD in Biomedical Engineering at Cornell University in 2015, where he leveraged synthetic biology approaches and cell biology to engineer bacteria and platelets as platforms to address cancer. Later, he performed postdoctoral training at MIT (2015-2018), where he gained new training in RNA chemistry and delivery. He was a tenure-track Assistant Professor in the Department of Bioengineering at Northeastern University from 2019 to 2023.

Dr. Li relocated the lab to the University of Michigan in the summer of 2023, and his research focuses on the development of molecular and live cell-based therapeutics to interrogate and manipulate interactions among therapeutics, the microbiome, and host.

Zoom:
https://umich.zoom.us/j/94801149707